<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Ma L</submitter><funding>NICHD NIH HHS</funding><funding>national Institute of Child Health and Human Development</funding><funding>ODCDC CDC HHS</funding><funding>NIMH NIH HHS</funding><funding>NIH HHS</funding><funding>National Institute of Child Health and Human Development</funding><pagination>849</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12197331</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>17(6)</volume><pubmed_abstract>Infants born to HIV-positive mothers remain at significant risk of HIV acquisition despite maternal adherence to antiretroviral therapy, cesarean delivery, and formula feeding. Our previous study reported that initiating early antiretroviral treatment at three days post-SIV infection resulted in approximately eighty percent of pediatric virologic remission. In this study, we investigated treatment outcomes in postnatally SHIV-exposed infant macaques when early intervention was delayed by two days, as well as the mechanisms underlying virologic control. The results showed that, although initiating treatment at five days post-exposure effectively suppressed viral replication, only one of the three infant macaques achieved a sustained state of virologic remission following analytical treatmen</pubmed_abstract><journal>Viruses</journal><pubmed_title>Impact of Delayed Early Antiretroviral Therapy Initiation on Treatment Outcomes in Infant Macaques Exposed to SHIVAD8.</pubmed_title><pmcid>PMC12197331</pmcid><funding_grant_id>U42 OD024282</funding_grant_id><funding_grant_id>P51 OD011104</funding_grant_id><funding_grant_id>R01 HD099857</funding_grant_id><funding_grant_id>HD099857</funding_grant_id><funding_grant_id>U42 OD010568</funding_grant_id><funding_grant_id>P40 OD028116</funding_grant_id><funding_grant_id>HD103511</funding_grant_id><funding_grant_id>R01 MH133474</funding_grant_id><pubmed_authors>Vincent E</pubmed_authors><pubmed_authors>Doyle-Meyers LA</pubmed_authors><pubmed_authors>Nishimura Y</pubmed_authors><pubmed_authors>Veazey RS</pubmed_authors><pubmed_authors>Ma L</pubmed_authors><pubmed_authors>Blair RV</pubmed_authors><pubmed_authors>Lu H</pubmed_authors><pubmed_authors>Donau O</pubmed_authors><pubmed_authors>Martin M</pubmed_authors><pubmed_authors>Wang X</pubmed_authors><pubmed_authors>Xu H</pubmed_authors><pubmed_authors>Wu X</pubmed_authors></additional><is_claimable>false</is_claimable><name>Impact of Delayed Early Antiretroviral Therapy Initiation on Treatment Outcomes in Infant Macaques Exposed to SHIVAD8.</name><description>Infants born to HIV-positive mothers remain at significant risk of HIV acquisition despite maternal adherence to antiretroviral therapy, cesarean delivery, and formula feeding. Our previous study reported that initiating early antiretroviral treatment at three days post-SIV infection resulted in approximately eighty percent of pediatric virologic remission. In this study, we investigated treatment outcomes in postnatally SHIV-exposed infant macaques when early intervention was delayed by two days, as well as the mechanisms underlying virologic control. The results showed that, although initiating treatment at five days post-exposure effectively suppressed viral replication, only one of the three infant macaques achieved a sustained state of virologic remission following analytical treatmen</description><dates><release>2025-01-01T00:00:00Z</release><publication>2025 Jun</publication><modification>2026-04-08T19:08:19.796Z</modification><creation>2026-04-08T12:01:29.712Z</creation></dates><accession>S-EPMC12197331</accession><cross_references><pubmed>40573440</pubmed><doi>10.3390/v17060849</doi></cross_references></HashMap>